Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-23
2008-09-23
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S331000
Reexamination Certificate
active
11433312
ABSTRACT:
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.
REFERENCES:
patent: 6531479 (2003-03-01), Wang et al.
patent: 0233461 (1987-08-01), None
patent: WO-95/09847 (1995-04-01), None
patent: WO-97/19065 (1997-05-01), None
patent: WO 01/72745 (2001-10-01), None
patent: WO-01/72745 (2001-10-01), None
Blain et al., Differential Interaction of the Cyclin-dependent kinase (Cdk) Inhibitor p27kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4, The Journal of Biological Chemistry, vol. 272, No. 41, pp. 25863-25872, 1997.
LuValle et al., Cell Cycle Control in Growth Plate Chondrocytes, Frontiers in Bioscience 5, d493-503, May 2001.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Traxler, Protein Tyrosine Kinase Inhibitors in cancer treatment, Expert Opinion on Therapeutic Patents, 7(6):571-588, 1997.
Paul, Rolf et al., “Preparation of SubstitutedN-Phenyl-4-aryl-2-pyrimidinamines as Mediator Release Inhibitors,”J. Med. Chem., vol. 36:2716-2725 (1993).
Zimmermann, Jürg et al., “Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC),”Arch. Pharm. Pharm. Med. Chem., vol. 329:371-376 (1996).
Fischer Peter Martin
Meades Christopher
Osnowski Andrew
Wang Shudong
Wood Gavin
Cyclacel Limited
Kanik Cynthia L.
Lahive & Cockfield LLP
Rao Deepak
Soroos, Esq. Cynthia M.
LandOfFree
N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3916619